BioNTech (BNTX) recently experienced a 10% price increase in the last quarter, coinciding with the Health Canada's authorization of its variant-adapted COMIRNATY COVID-19 vaccine, a potential positive ...

Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX) "BioNTech" announced today that Health Canada has authorized the LP.8.1 ...

Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...

You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...

A large retrospective study found that nearly a quarter of high-grade serous cancers occurred after missed chances to perform ...

The top executives running the health care industry’s blue-chip companies amassed generational wealth in 2024, even as many ...

The outcome of this study could significantly influence BioNTech’s stock performance and investor sentiment, especially if the combination therapy proves more effective than the standard treatment.

Pfizer said Health Canada has approved its latest COVID-19 vaccine that targets a new Omicron variant. It will be made available in the fall.

"This isn't a political statement," Dr. Lee Vogel said about vaccine safety. "This is just trying to provide some factual information for people." ...

The American Academy of Pediatrics breaks with federal guidance, urging COVID shots for young kids as Kennedy's panel delays ...

Alberta's government says it will cover the cost of COVID-19 vaccinations for health-care workers in a partial policy ...

The American Academy of Pediatrics says children 6 months to 2 years old really need a COVID vaccine, while the CDC says they ...